Experimental and Clinical Psychopharmacology

Top Research Topics at Experimental and Clinical Psychopharmacology?

Experimental and Clinical Psychopharmacology is mainly concerned with subjects like Clinical psychology, Psychiatry, Anesthesia, Developmental psychology and Nicotine. Experimental and Clinical Psychopharmacology explores topics in Clinical psychology which can be helpful for research in disciplines like Young adult, Cognition, Placebo, PsycINFO and Craving. Studies on Placebo discussed in the journal link to the field of Randomized controlled trial.

Topics in PsycINFO explored in Experimental and Clinical Psychopharmacology were investigated in conjunction with research in Psychological intervention and Cannabis. Substance abuse, Abstinence, Impulsivity, Alcohol abuse and Mood are all topics related to Psychiatry research discussed. The study on Substance abuse presented in it intersects with subjects under the field of Addiction.

Anesthesia research discussed connects with the study of Pharmacology. Developmental psychology study tackled is connected to the field of Audiology. The journal focuses on Nicotine research as part of the broader topic of Internal medicine.

• Clinical psychology (26.12%)
• Psychiatry (21.94%)
• Anesthesia (12.31%)

What are the most cited papers published in the journal?

• Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: Basic findings from the National Comorbidity Survey. (1128 citations)
• Impulsive and self-control choices in opioid-dependent patients and non-drug-using control patients: Drug and monetary rewards. (798 citations)
• Hyperbolic temporal discounting in social drinkers and problem drinkers. (528 citations)

Research areas of the most cited articles at Experimental and Clinical Psychopharmacology:

The most cited papers are organized to reinforce research efforts on Psychiatry, Clinical psychology, Developmental psychology, Substance abuse and Cognition. The most cited papers dive deep in exploring the relationship between the study of Psychiatry and Placebo. The most cited publications explore topics in Developmental psychology which can be helpful for research in disciplines like Expectancy theory and Audiology.

What topics the last edition of the journal is best known for?

• Internal medicine
• Cognition
• Social psychology

The previous edition focused in particular on these issues:

Experimental and Clinical Psychopharmacology covers a variety of subjects, including PsycINFO, Clinical psychology, Cannabis, Psychological intervention and Nicotine. In the journal, Intervention (counseling), Young adult, Abstinence, Discounting and Alcohol use disorder are investigated in conjunction with one another to address concerns in PsycINFO research. The discussions emphasized the topic of Abstinence in an attempt to further explore the field of Psychiatry.

While Experimental and Clinical Psychopharmacology focused on Discounting, it was also able to explore topics like Chronic pain and Substance abuse. Issues in Clinical psychology were discussed, taking into consideration concepts from other disciplines like Placebo, Sensation seeking and Craving. The close relationship between Reinforcement and Extinction (psychology) and Preference is one of the points of interest dissected in Nicotine research.

The most cited articles from the last journal are:

• Effects of Δ⁹-tetrahydrocannabinol (THC) vapor inhalation in Sprague-Dawley and Wistar rats. (14 citations)
• Cigarette smoke-induced alterations in blood: A review of research on DNA methylation and gene expression. (7 citations)
• Conditioned enhancement of the nicotine reinforcer. (7 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Experimental and Clinical Psychopharmacology (based on the number of publications) are:

• Warren K. Bickel (51 papers) published 5 papers at the last edition, 2 more than at the previous edition,
• Stephen T. Higgins (37 papers) published 1 paper at the last edition, 2 less than at the previous edition,
• James G. Murphy (29 papers) published 5 papers at the last edition, 2 more than at the previous edition,
• Mark T. Fillmore (28 papers) absent at the last edition,
• James MacKillop (24 papers) published 3 papers at the last edition the same number as at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Experimental and Clinical Psychopharmacology (based on the number of publications) are:

• University of Kentucky (66 papers) published 2 papers at the last edition, 1 less than at the previous edition,
• University of Vermont (53 papers) published 2 papers at the last edition, 2 less than at the previous edition,
• Yale University (49 papers) published 3 papers at the last edition the same number as at the previous edition,
• Johns Hopkins University School of Medicine (48 papers) published 5 papers at the last edition the same number as at the previous edition,
• Johns Hopkins University (44 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 39.83% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 19.72% were posted by at least one author from the top 10 institutions publishing in the journal. Another 18.31% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 21.13% of all publications and 40.85% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Experimental and Clinical Psychopharmacology

Apart from research, individuals interested in Experimental and Clinical Psychopharmacology can explore various career paths. Many practitioners in this field often translate their research capabilities into direct roles in different industries. One of the most common career paths is becoming a forensic scientist. As a forensic scientist, individuals use their understanding of pharmacology and its associated disciplines to analyze substances, chemicals, and other excerpts related to legal investigations.

The role of a forensic scientist is not easy but requires a meticulous and alert mind that is trained thoughtfully. If you are in Ohio and considering a career shift or starting a career in psychopharmacology, becoming a forensic scientist could be an exciting option to consider. You can read this detailed guide on how to be a forensic scientist in Ohio to get a good start.

Other career paths that are closely related to Experimental and Clinical Psychopharmacology include becoming a clinical psychologist, a psychiatry practitioner, an anesthesiologist, or a researcher in other closely related disciplines. Regardless of the path you decide to follow, it's essential to stay up to-date on new studies, trends, articles, and papers in this scientific field.